作为BCKDK缺乏症的潜在治疗方法,部分抑制BCAA代谢
Laura Ohl1,2, Amanda Kuhs1, Ryan Pluck1
1Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA.
Molecular genetics and metabolism reports
|May 21, 2024
概括
分支链酸脱酶激酶 (BCKDK) 缺陷治疗与BCAA补充在小鼠模型中恶化症状. 异常的BCAA代谢,而不是不足,可能会驱动疾病病理,建议新的治疗途径.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 神经学 神经学
背景情况:
- 分支链酸脱酶激酶 (BCKDK) 缺乏症是一种罕见的遗传神经代谢障碍.
- 这种情况涉及异常的分支链氨基酸 (BCAA) 代谢和增加的 BCAA 代谢.
- 目前的假设表明BCAA不足是疾病的基础,建议补充作为治疗策略.
研究的目的:
- 在BCKDK缺乏症的小鼠模型中研究BCAA补充剂的疗效.
- 探索BCKDK缺乏的潜在病理生理学.
主要方法:
- 一种针对BCKDK缺陷的新型小鼠模型的表征.
- 在小鼠模型中对肠道BCAA补充剂的评估.
- 基因操纵 (Dbt哈普洛缺陷) 来重新调节BCAA代谢.
主要成果:
- 在小鼠模型中,BCAA补充会加剧神经发育缺陷.
- 补充剂未能纠正生物化学异常,尽管增加了全身BCAA水平.
- 生物化学和行为表型的部分救援观察到Dbt的哈普洛缺陷.
结论:
- 这些发现挑战了BCAA不足是BCKDK缺乏的主要驱动因素的假设.
- 在BCAA代谢途径内的异常流动似乎对疾病病理学有重大贡献.
- 这些结果表明,针对BCKDK缺乏症的BCAA代谢调节的新型治疗策略.
相关概念视频
Depolarizing Blockers: Pharmocokinetics
319
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
319
Overview of Protein Metabolism
1.0K
Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
1.0K
Myasthenia Gravis: Overview and Treatment
1.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.4K
Allosteric Proteins-ATCase
5.7K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.7K
Skeletal Muscle Relaxants: Adverse Effects
356
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
356
cAMP-dependent Protein Kinase Pathways
6.3K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.3K


